Author Correction: Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes

Author Correction: Mir142 loss unlocks IDH2^R140-dependent leukemogenesis through antagonistic regulation of HOX genes

Sci Rep. 2021 Mar 23;11(1):6974. doi: 10.1038/s41598-021-84578-y.

A Marshall^#¹, J Kasturiarachchi^#¹, P Datta¹, Y Guo¹, E Deltcheva¹, C James^{1

2}, J Brown¹, G May¹, N Anandagoda³, I Jackson³, J K Howard⁴, E Ghazaly^{5

6}, S Brooks¹, A Khwaja¹, M Araki⁷, K Araki⁷, D Linch¹, G M Lord⁸, T Enver¹, R Nimmo^{9

10}

¹ UCL Cancer Institute, University College London, London, UK.
² The Institute of Cancer Research, London, UK.
³ School of Immunology and Microbial Sciences, King's College London, London, UK.
⁴ School of Life Course Sciences, King's College London, London, UK.
⁵ Centre for Haemato‑Oncology, Barts Cancer Institute, Queen Mary University of London, London, Queen, UK.
⁶ Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK.
⁷ Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan.
⁸ Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
⁹ UCL Cancer Institute, University College London, London, UK. r.nimmo@oxb.com.
¹⁰ Oxford Biomedica (UK) Ltd, Windrush Court, Transport Way, Oxford, OX4 6LT, UK. r.nimmo@oxb.com.

^# Contributed equally.

No abstract available